19-32830541-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014270.5(SLC7A9):c.*79T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.164 in 1,086,512 control chromosomes in the GnomAD database, including 15,484 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2442 hom., cov: 32)
Exomes 𝑓: 0.16 ( 13042 hom. )
Consequence
SLC7A9
NM_014270.5 3_prime_UTR
NM_014270.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.408
Genes affected
SLC7A9 (HGNC:11067): (solute carrier family 7 member 9) This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-32830541-A-G is Benign according to our data. Variant chr19-32830541-A-G is described in ClinVar as [Benign]. Clinvar id is 328740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-32830541-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.193 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A9 | NM_014270.5 | c.*79T>C | 3_prime_UTR_variant | 13/13 | ENST00000023064.9 | NP_055085.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC7A9 | ENST00000023064.9 | c.*79T>C | 3_prime_UTR_variant | 13/13 | 1 | NM_014270.5 | ENSP00000023064 | P1 | ||
SLC7A9 | ENST00000590341.5 | c.*79T>C | 3_prime_UTR_variant | 13/13 | 1 | ENSP00000464822 | P1 | |||
SLC7A9 | ENST00000590465.5 | c.*1690T>C | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 2 | ENSP00000468076 | ||||
SLC7A9 | ENST00000592232.5 | downstream_gene_variant | 1 | ENSP00000465563 |
Frequencies
GnomAD3 genomes AF: 0.174 AC: 26531AN: 152058Hom.: 2438 Cov.: 32
GnomAD3 genomes
AF:
AC:
26531
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.163 AC: 152149AN: 934336Hom.: 13042 Cov.: 13 AF XY: 0.162 AC XY: 78821AN XY: 488020
GnomAD4 exome
AF:
AC:
152149
AN:
934336
Hom.:
Cov.:
13
AF XY:
AC XY:
78821
AN XY:
488020
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.175 AC: 26559AN: 152176Hom.: 2442 Cov.: 32 AF XY: 0.174 AC XY: 12979AN XY: 74402
GnomAD4 genome
AF:
AC:
26559
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
12979
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
653
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 11, 2020 | - - |
Cystinuria Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at